{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:42:04Z","timestamp":1790109724387,"version":"4.0.1"},"reference-count":33,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C1169"],"award-info":[{"award-number":["HI18C1169"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["02-2018-0027"],"award-info":[{"award-number":["02-2018-0027"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Hip adductor spasticity is a contributing factor to hip dislocation in patients with cerebral palsy (CP). We hypothesized that botulinum toxin injected into the hip adductor muscles would reduce spasticity and help prevent hip dislocation. Twenty patients with bilateral spastic CP aged 2 to 10 years with gross motor function classification system level IV or V were included. Botulinum toxin was injected into the hip adductor muscles at baseline and at 6-month follow-up. Muscle tone was measured with an eight-channel surface electromyography (EMG) recorder. A hip X-ray was performed, and Reimer\u2019s hip migration index (MI) was measured. The Wilcoxon signed-rank test was used to compare the surface EMG values of the hip muscles at baseline and follow-up. The mean root mean square surface EMG value of the hip adductor muscles was significantly reduced at 1, 2, 3, and 7 months after the first injection, up to approximately 53% of the baseline. The 1-year progression of the hip MI was \u22120.04%. Repeated sessions of botulinum toxin injections at the hip adductor muscles significantly reduced muscle tone and hip displacement. A botulinum toxin injection may be used as an adjunctive treatment in the prevention of hip dislocation.<\/jats:p>","DOI":"10.3390\/toxins13120872","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T03:21:05Z","timestamp":1638847265000},"page":"872","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of Botulinum Toxin Injection on the Progression of Hip Dislocation in Patients with Spastic Cerebral Palsy: A Pilot Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4282-9848","authenticated-orcid":false,"given":"Yookyung","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungeun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si 13620, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonyoung","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si 13620, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoon","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si 13620, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3299-3038","authenticated-orcid":false,"given":"Ju Seok","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si 13620, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1302\/0301-620X.90B10.20733","article-title":"Proximal femoral geometry in cerebral palsy: A population-based cross-sectional study","volume":"90","author":"Robin","year":"2008","journal-title":"J. Bone Jt. Surg.\u2014Ser. B"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/dmcn.13437","article-title":"Functional status and amount of hip displacement independently affect acetabular dysplasia in cerebral palsy","volume":"59","author":"Chung","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ocl.2010.07.002","article-title":"Management of Hip deformities in cerebral palsy","volume":"41","author":"Valencia","year":"2010","journal-title":"Orthop. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.apmr.2018.07.423","article-title":"Are Seating Systems with a Medial Knee Support Really Helpful for Hip Displacement in Children with Spastic Cerebral Palsy GMFCS IV and V?","volume":"100","author":"Kim","year":"2019","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/PHM.0000000000001261","article-title":"The Mechanism of Hip Dislocation Related to the Use of Abduction Bar and Hip Compression Bandage in Patients with Spastic Cerebral Palsy","volume":"98","author":"Kim","year":"2019","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2519\/jospt.2010.3025","article-title":"Kinesiology of the hip: A focus on muscular actions","volume":"40","author":"Neumann","year":"2010","journal-title":"J. Orthop. Sports Phys. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/toxins7051629","article-title":"Best clinical practice in botulinum toxin treatment for children with cerebral palsy","volume":"7","author":"Strobl","year":"2015","journal-title":"Toxins"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/dmcn.13480","article-title":"Prevention of hip displacement in children with cerebral palsy: A systematic review","volume":"59","author":"Miller","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.apmr.2008.04.019","article-title":"Comparison of Botulinum Toxin Type A Injection and Soft-Tissue Surgery to Treat Hip Subluxation in Children with Cerebral Palsy","volume":"89","author":"Yang","year":"2008","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2003-43549","article-title":"Treatment of Lateralisation and Subluxation of the Hip in Cerebral Palsy with Botulinum Toxin A: Preliminary Results Based on the Analysis of Migration Percentage Data","volume":"35","author":"Placzek","year":"2004","journal-title":"Neuropediatrics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.apmr.2004.03.034","article-title":"Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A","volume":"86","author":"Pidcock","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0031-1275344","article-title":"Hip lateralisation in children with bilateral spastic cerebral palsy treated with botulinum toxin type A: A 2-year follow-up","volume":"42","author":"Jung","year":"2011","journal-title":"Neuropediatrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1469-8749.2012.04340.x","article-title":"The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy","volume":"54","author":"Willoughby","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2106\/JBJS.F.01416","article-title":"Does botulinum toxin A combined with bracing prevent hip displacement in children with cerebral palsy and \u201chips at risk\u201d? A randomized, controlled trial","volume":"90","author":"Graham","year":"2008","journal-title":"J. Bone Jt. Surg.\u2014Ser. A"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lin, C.-Y., Chung, C.-H., Matthews, D.J., Chu, H.-Y., Chen, L.-C., Yang, S.-S., and Chien, W.-C. (2021). Long-term effect of botulinum toxin A on the hip and spine in cerebral palsy: A national retrospective cohort study in Taiwan. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0255143"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40272-019-00344-8","article-title":"Botulinum Toxin in the Management of Children with Cerebral Palsy","volume":"21","author":"Multani","year":"2019","journal-title":"Pediatr. Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/mds.22661","article-title":"Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers","volume":"24","author":"Schroeder","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/dsu.12125","article-title":"Muscle atrophy beyond the clinical effect after a single dose of onabotulinumtoxina injected in the procerus muscle: A study with magnetic resonance imaging","volume":"39","author":"Koerte","year":"2013","journal-title":"Dermatol. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2106\/JBJS.RVW.18.00153","article-title":"Sarcopenia, cerebral palsy, and botulinum toxin type A","volume":"7","author":"Multani","year":"2019","journal-title":"JBJS Rev."},{"key":"ref_20","first-page":"981-e38","article-title":"European consensus on the concepts and measurement of the pathophysiological neuromuscular responses to passive muscle stretch","volume":"24","author":"Bonikowski","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1152\/jn.00084.2018","article-title":"Muscle coactivation: Definitions, mechanisms, and functions","volume":"120","author":"Latash","year":"2018","journal-title":"J. Neurophysiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/dmcn.13502","article-title":"Identification and measurement of dystonia in cerebral palsy","volume":"59","author":"Rice","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1469-8749.2012.04385.x","article-title":"The natural history of hip development in cerebral palsy","volume":"54","author":"Terjesen","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/09638288.2014.932449","article-title":"Transcultural adaptation and validation of the Korean version of Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD)","volume":"37","author":"Sung","year":"2015","journal-title":"Disabil. Rehabil."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2014.01.050","article-title":"Botulinum toxin a for nonambulatory children with cerebral palsy: A double blind randomized controlled trial","volume":"165","author":"Copeland","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mutlu, A., Livanelioglu, A., and Gunel, M.K. (2008). Reliability of Ashworth and Modified Ashworth Scales in children with spastic cerebral palsy. BMC Musculoskelet. Disord., 9.","DOI":"10.1186\/1471-2474-9-44"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102438","DOI":"10.1016\/j.jelekin.2020.102438","article-title":"Consensus for experimental design in electromyography (CEDE) project: Amplitude normalization matrix","volume":"53","author":"Besomi","year":"2020","journal-title":"J. Electromyogr. Kinesiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"H\u00e4gglund, G., Lauge-Pedersen, H., and Wagner, P. (2007). Characteristics of children with hip displacement in cerebral palsy. BMC Musculoskelet. Disord., 8.","DOI":"10.1186\/1471-2474-8-101"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1542\/neo.7-11-e569","article-title":"The Definition and Classification of Cerebral Palsy: Are We Any Further Ahead in 2006?","volume":"7","author":"Rosenbaum","year":"2006","journal-title":"Neoreviews"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/BPB.0000000000000579","article-title":"The popliteal angle tests in patients with cerebral palsy","volume":"28","author":"Manikowska","year":"2019","journal-title":"J. Pediatr. Orthop. Part B"},{"key":"ref_31","unstructured":"(2021, December 06). AACPDM\u2014Hip Surveillance in Cerebral Palsy. Available online: https:\/\/www.aacpdm.org\/publications\/care-pathways\/hip-surveillance-in-cerebral-palsy."},{"key":"ref_32","unstructured":"(2021, December 06). AusACPDM\u2014Australian Hip Surveillance Guidelines. Available online: https:\/\/www.ausacpdm.org.au\/resources\/australian-hip-surveillance-guidelines\/."},{"key":"ref_33","unstructured":"(2021, December 06). CHBC Hip Surveillance Program for Children with Cerebral Palsy. Available online: https:\/\/www.childhealthbc.ca\/initiatives\/chbc-hip-surveillance-program-children-cerebral-palsy."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/13\/12\/872\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:42:06Z","timestamp":1760168526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/13\/12\/872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["toxins13120872"],"URL":"https:\/\/doi.org\/10.3390\/toxins13120872","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}